Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205071334> ?p ?o ?g. }
- W3205071334 abstract "DNA methylation detection in liquid biopsies provides a highly promising and much needed means for real-time monitoring of disease load in advanced cancer patient care. Compared to the often-used somatic mutations, tissue- and cancer-type specific epigenetic marks affect a larger part of the cancer genome and generally have a high penetrance throughout the tumour. Here, we describe the successful application of the recently described MeD-seq assay for genome-wide DNA methylation profiling on cell-free DNA (cfDNA). The compatibility of the MeD-seq assay with different types of blood collection tubes, cfDNA input amounts, cfDNA isolation methods, and vacuum concentration of samples was evaluated using plasma from both metastatic cancer patients and healthy blood donors (HBDs). To investigate the potential value of cfDNA methylation profiling for tumour load monitoring, we profiled paired samples from 8 patients with resectable colorectal liver metastases (CRLM) before and after surgery.The MeD-seq assay worked on plasma-derived cfDNA from both EDTA and CellSave blood collection tubes when at least 10 ng of cfDNA was used. From the 3 evaluated cfDNA isolation methods, both the manual QIAamp Circulating Nucleic Acid Kit (Qiagen) and the semi-automated Maxwell® RSC ccfDNA Plasma Kit (Promega) were compatible with MeD-seq analysis, whereas the QiaSymphony DSP Circulating DNA Kit (Qiagen) yielded significantly fewer reads when compared to the QIAamp kit (p < 0.001). Vacuum concentration of samples before MeD-seq analysis was possible with samples in AVE buffer (QIAamp) or water, but yielded inconsistent results for samples in EDTA-containing Maxwell buffer. Principal component analysis showed that pre-surgical samples from CRLM patients were very distinct from HBDs, whereas post-surgical samples were more similar. Several described methylation markers for colorectal cancer monitoring in liquid biopsies showed differential methylation between pre-surgical CRLM samples and HBDs in our data, supporting the validity of our approach. Results for MSC, ITGA4, GRIA4, and EYA4 were validated by quantitative methylation specific PCR.The MeD-seq assay provides a promising new method for cfDNA methylation profiling. Potential future applications of the assay include marker discovery specifically for liquid biopsy analysis as well as direct use as a disease load monitoring tool in advanced cancer patients." @default.
- W3205071334 created "2021-10-25" @default.
- W3205071334 creator A5001564817 @default.
- W3205071334 creator A5003517226 @default.
- W3205071334 creator A5012688071 @default.
- W3205071334 creator A5029260009 @default.
- W3205071334 creator A5037096964 @default.
- W3205071334 creator A5047837719 @default.
- W3205071334 creator A5048187760 @default.
- W3205071334 creator A5063039968 @default.
- W3205071334 creator A5066926133 @default.
- W3205071334 creator A5077780102 @default.
- W3205071334 creator A5078332643 @default.
- W3205071334 creator A5079636721 @default.
- W3205071334 creator A5082811144 @default.
- W3205071334 creator A5085813010 @default.
- W3205071334 creator A5088635442 @default.
- W3205071334 creator A5090734944 @default.
- W3205071334 date "2021-10-20" @default.
- W3205071334 modified "2023-10-01" @default.
- W3205071334 title "High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments" @default.
- W3205071334 cites W1976896356 @default.
- W3205071334 cites W2079700746 @default.
- W3205071334 cites W2108084801 @default.
- W3205071334 cites W2114570899 @default.
- W3205071334 cites W2156165856 @default.
- W3205071334 cites W2170551349 @default.
- W3205071334 cites W2533450137 @default.
- W3205071334 cites W2586174920 @default.
- W3205071334 cites W2608738563 @default.
- W3205071334 cites W2617060850 @default.
- W3205071334 cites W2756471067 @default.
- W3205071334 cites W2760986701 @default.
- W3205071334 cites W2775229688 @default.
- W3205071334 cites W2791176983 @default.
- W3205071334 cites W2794803931 @default.
- W3205071334 cites W2804563464 @default.
- W3205071334 cites W2842070493 @default.
- W3205071334 cites W2888992486 @default.
- W3205071334 cites W2895672952 @default.
- W3205071334 cites W2900771557 @default.
- W3205071334 cites W2948436745 @default.
- W3205071334 cites W2952214509 @default.
- W3205071334 cites W2965294890 @default.
- W3205071334 cites W2970087737 @default.
- W3205071334 cites W2978385311 @default.
- W3205071334 cites W2981193994 @default.
- W3205071334 cites W2990870977 @default.
- W3205071334 cites W3013924915 @default.
- W3205071334 cites W3031471547 @default.
- W3205071334 cites W3033275946 @default.
- W3205071334 cites W3042448685 @default.
- W3205071334 cites W4211139125 @default.
- W3205071334 doi "https://doi.org/10.1186/s13148-021-01177-4" @default.
- W3205071334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8529776" @default.
- W3205071334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34670587" @default.
- W3205071334 hasPublicationYear "2021" @default.
- W3205071334 type Work @default.
- W3205071334 sameAs 3205071334 @default.
- W3205071334 citedByCount "7" @default.
- W3205071334 countsByYear W32050713342022 @default.
- W3205071334 countsByYear W32050713342023 @default.
- W3205071334 crossrefType "journal-article" @default.
- W3205071334 hasAuthorship W3205071334A5001564817 @default.
- W3205071334 hasAuthorship W3205071334A5003517226 @default.
- W3205071334 hasAuthorship W3205071334A5012688071 @default.
- W3205071334 hasAuthorship W3205071334A5029260009 @default.
- W3205071334 hasAuthorship W3205071334A5037096964 @default.
- W3205071334 hasAuthorship W3205071334A5047837719 @default.
- W3205071334 hasAuthorship W3205071334A5048187760 @default.
- W3205071334 hasAuthorship W3205071334A5063039968 @default.
- W3205071334 hasAuthorship W3205071334A5066926133 @default.
- W3205071334 hasAuthorship W3205071334A5077780102 @default.
- W3205071334 hasAuthorship W3205071334A5078332643 @default.
- W3205071334 hasAuthorship W3205071334A5079636721 @default.
- W3205071334 hasAuthorship W3205071334A5082811144 @default.
- W3205071334 hasAuthorship W3205071334A5085813010 @default.
- W3205071334 hasAuthorship W3205071334A5088635442 @default.
- W3205071334 hasAuthorship W3205071334A5090734944 @default.
- W3205071334 hasBestOaLocation W32050713341 @default.
- W3205071334 hasConcept C104317684 @default.
- W3205071334 hasConcept C121608353 @default.
- W3205071334 hasConcept C126322002 @default.
- W3205071334 hasConcept C143998085 @default.
- W3205071334 hasConcept C150194340 @default.
- W3205071334 hasConcept C152110520 @default.
- W3205071334 hasConcept C153911025 @default.
- W3205071334 hasConcept C172680121 @default.
- W3205071334 hasConcept C190727270 @default.
- W3205071334 hasConcept C2778258057 @default.
- W3205071334 hasConcept C2779234561 @default.
- W3205071334 hasConcept C2779529041 @default.
- W3205071334 hasConcept C33288867 @default.
- W3205071334 hasConcept C41091548 @default.
- W3205071334 hasConcept C49105822 @default.
- W3205071334 hasConcept C526805850 @default.
- W3205071334 hasConcept C54355233 @default.
- W3205071334 hasConcept C552990157 @default.
- W3205071334 hasConcept C71924100 @default.
- W3205071334 hasConcept C78063203 @default.